{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T00:51:47Z","timestamp":1794185507250,"version":"4.8.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["R01EY028027"],"award-info":[{"award-number":["R01EY028027"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["R01EY29799"],"award-info":[{"award-number":["R01EY29799"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["R01EY031039"],"award-info":[{"award-number":["R01EY031039"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Eye Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Eye Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nonfibrillar amyloid-\u03b2 oligomers (A\u03b2Os) are a major component of drusen, the sub-retinal pigmented epithelium (RPE) extracellular deposits characteristic of age-related macular degeneration (AMD), a common cause of global blindness. We report that A\u03b2Os induce RPE degeneration, a clinical hallmark of geographic atrophy (GA), a vision-threatening late stage of AMD that is currently untreatable. We demonstrate that A\u03b2Os induce activation of the NLRP3 inflammasome in the mouse RPE in vivo and that RPE expression of the purinergic ATP receptor P2RX7, an upstream mediator of NLRP3 inflammasome activation, is required for A\u03b2O-induced RPE degeneration. Two classes of small molecule inflammasome inhibitors\u2014nucleoside reverse transcriptase inhibitors (NRTIs) and their antiretrovirally inert modified analog Kamuvudines\u2014both inhibit A\u03b2Os-induced RPE degeneration. These findings crystallize the importance of P2RX7 and NLRP3 in a disease-relevant model of AMD and identify inflammasome inhibitors as potential treatments for GA.<\/jats:p>","DOI":"10.1038\/s41392-021-00537-z","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:03:00Z","timestamp":1618358580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-\u03b2 induced retinal pigmented epithelium degeneration"],"prefix":"10.1038","volume":"6","author":[{"given":"Siddharth","family":"Narendran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8884-2816","authenticated-orcid":false,"given":"Felipe","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Yerramothu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Apicella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kameshwari","family":"Ambati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichiro","family":"Hirahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younghee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Ambati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya L.","family":"Ambati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peirong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhil","family":"Varshney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Nagasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstie L.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1275-5729","authenticated-orcid":false,"given":"Kenneth M.","family":"Marion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Deussing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas R.","family":"Sadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley D.","family":"Gelfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayakrishna","family":"Ambati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,14]]},"reference":[{"key":"537_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ophtha.2011.09.027","volume":"119","author":"AR Rudnicka","year":"2012","unstructured":"Rudnicka, A. R. et al. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 119, 571\u2013580 (2012).","journal-title":"Ophthalmology"},{"key":"537_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuron.2012.06.018","volume":"75","author":"J Ambati","year":"2012","unstructured":"Ambati, J. & Fowler, B. J. Mechanisms of age-related macular degeneration. Neuron 75, 26\u201339 (2012).","journal-title":"Neuron"},{"key":"537_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1172\/JCI25843","volume":"116","author":"V Luibl","year":"2006","unstructured":"Luibl, V. et al. Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. J. Clin. Investig. 116, 378\u2013385 (2006).","journal-title":"J. Clin. Investig."},{"key":"537_CR4","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1167\/iovs.09-4207","volume":"51","author":"JM Isas","year":"2010","unstructured":"Isas, J. M. et al. Soluble and mature amyloid fibrils in drusen deposits. Investig. Ophthalmol. Vis. Sci. 51, 1304\u20131310 (2010).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"537_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.preteyeres.2011.02.004","volume":"30","author":"K Ohno-Matsui","year":"2011","unstructured":"Ohno-Matsui, K. Parallel findings in age-related macular degeneration and Alzheimer\u2019s disease. Prog. Retinal Eye Res. 30, 217\u2013238 (2011).","journal-title":"Prog. Retinal Eye Res."},{"key":"537_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3233\/JAD-2011-110182","volume":"24","author":"BS Gadad","year":"2011","unstructured":"Gadad, B. S., Britton, G. B. & Rao, K. S. Targeting oligomers in neurodegenerative disorders: Lessons from \u03b1-synuclein, tau, and amyloid-\u03b2 peptide. J. Alzheimer\u2019s Dis. 24, 223\u2013232 (2011).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"537_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz, P. & Dixit, V. M. Inflammasomes: mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 16, 407\u2013420 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"537_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuroscience.2018.02.046","volume":"405","author":"C Fekete","year":"2019","unstructured":"Fekete, C. et al. Chronic amyloid \u03b2 oligomer infusion evokes sustained inflammation and microglial changes in the rat hippocampus via NLRP3. Neuroscience 405, 35\u201346 (2019).","journal-title":"Neuroscience"},{"key":"537_CR9","doi-asserted-by":"crossref","unstructured":"Nakanishi, A. et al. Amyloid \u03b2 directly interacts with NLRP3 to initiate inflammasome activation: identification of an intrinsic NLRP3 ligand in a cell-free system. Inflamm. Regen. 38, 1\u20138 (2018).","DOI":"10.1186\/s41232-018-0085-6"},{"key":"537_CR10","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle, A. et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-\u03b2. Nat. Immunol. 9, 857\u2013865 (2008).","journal-title":"Nat. Immunol."},{"key":"537_CR11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2012.03.036","volume":"149","author":"V Tarallo","year":"2012","unstructured":"Tarallo, V. et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 149, 847\u2013859 (2012).","journal-title":"Cell"},{"key":"537_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1167\/iovs.12-10655","volume":"54","author":"WA Tseng","year":"2013","unstructured":"Tseng, W. A. et al. NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 54, 110\u2013120 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"537_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nm.4450","volume":"24","author":"N Kerur","year":"2018","unstructured":"Kerur, N. et al. CGAS drives noncanonical-inflammasome activation in age-related macular degeneration. Nat. Med. 24, 50\u201361 (2018).","journal-title":"Nat. Med."},{"key":"537_CR14","doi-asserted-by":"crossref","unstructured":"Swanson, K. V., Deng, M. & Ting, J. P. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 19, 477\u2013489 (2019).","DOI":"10.1038\/s41577-019-0165-0"},{"key":"537_CR15","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.cell.2014.02.008","volume":"156","author":"A Lu","year":"2014","unstructured":"Lu, A. et al. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 156, 1193\u20131206 (2014).","journal-title":"Cell"},{"key":"537_CR16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","volume":"47","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L. & Falzoni, S. The P2X7 Receptor in Infection and Inflammation. Immunity 47, 15\u201331 (2017).","journal-title":"Immunity"},{"key":"537_CR17","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1126\/science.1261754","volume":"346","author":"BJ Fowler","year":"2014","unstructured":"Fowler, B. J. et al. Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity. Science 346, 1000\u20131003 (2014).","journal-title":"Science"},{"key":"537_CR18","doi-asserted-by":"publisher","first-page":"7395","DOI":"10.1167\/iovs.13-12500","volume":"54","author":"N Kerur","year":"2013","unstructured":"Kerur, N. et al. TLR-independent and P2X7-dependent signaling mediate Alu RNA-induced NLRP3 inflammasome activation in geographic atrophy. Invest. Ophthalmol. Vis. Sci. 54, 7395\u20137401 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"537_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bbrc.2016.10.140","volume":"482","author":"KA Carver","year":"2017","unstructured":"Carver, K. A., Lin, C. M., Bowes Rickman, C. & Yang, D. Lack of the P2X7 receptor protects against AMD-like defects and microparticle accumulation in a chronic oxidative stress-induced mouse model of AMD. Biochem. Biophys. Res. Commun. 482, 81\u201386 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"537_CR20","doi-asserted-by":"crossref","unstructured":"Yang, D. Targeting the p2x7 receptor in age-related macular degeneration. Vision 1, 11 (2017).","DOI":"10.3390\/vision1020011"},{"key":"537_CR21","doi-asserted-by":"crossref","unstructured":"Chiozzi, P. et al. Amyloid \u03b2-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine. Sci. Rep. 9, 1\u201315 (2019).","DOI":"10.1038\/s41598-019-42931-2"},{"key":"537_CR22","doi-asserted-by":"publisher","first-page":"11637","DOI":"10.7150\/thno.48064","volume":"10","author":"J Sun","year":"2020","unstructured":"Sun, J. et al. ROS production and mitochondrial dysfunction driven by PU.1-regulated NOX4-p22phox activation in A\u03b2-induced retinal pigment epithelial cell injury. Theranostics 10, 11637\u201311655 (2020).","journal-title":"Theranostics"},{"key":"537_CR23","doi-asserted-by":"publisher","first-page":"5230","DOI":"10.4049\/jimmunol.1301490","volume":"191","author":"ME Heid","year":"2013","unstructured":"Heid, M. E. et al. Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation. J. Immunol. 191, 5230\u20135238 (2013).","journal-title":"J. Immunol."},{"key":"537_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1062-3","volume":"15","author":"J Gao","year":"2018","unstructured":"Gao, J., Cui, J. Z., To, E., Cao, S. & Matsubara, J. A. Evidence for the activation of pyroptotic and apoptotic pathways in RPE cells associated with NLRP3 inflammasome in the rodent eye. J. Neuroinflammation 15, 15 (2018).","journal-title":"J. Neuroinflammation"},{"key":"537_CR25","doi-asserted-by":"crossref","unstructured":"Wang, K. et al. Amyloid \u03b2 induces NLRP3 inflammasome activation in retinal pigment epithelial cells via NADPH oxidase- and mitochondria-dependent ROS production. J. Biochem. Mol. Toxicol. 31, e21887 (2017).","DOI":"10.1002\/jbt.21887"},{"key":"537_CR26","doi-asserted-by":"crossref","unstructured":"Liu, R. T. et al. Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 54, 2225\u20132237 (2013).","DOI":"10.1167\/iovs.12-10849"},{"key":"537_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0784-9","volume":"566","author":"M De Cecco","year":"2019","unstructured":"De Cecco, M. et al. L1 drives IFN in senescent cells and promotes age-associated inflammation. Nature 566, 73\u201378 (2019).","journal-title":"Nature"},{"key":"537_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0530-4","volume":"6","author":"R Al-Khalidi","year":"2018","unstructured":"Al-Khalidi, R. et al. Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism. Acta Neuropathol. Commun. 6, 27 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"537_CR29","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nrd1201","volume":"2","author":"W Lewis","year":"2003","unstructured":"Lewis, W., Day, B. J. & Copeland, W. C. Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat. Rev. Drug Discov. 2, 812\u2013822 (2003).","journal-title":"Nat. Rev. Drug Discov."},{"key":"537_CR30","doi-asserted-by":"publisher","first-page":"40847","DOI":"10.1074\/jbc.M106743200","volume":"276","author":"AA Johnson","year":"2001","unstructured":"Johnson, A. A. et al. Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase. J. Biol. Chem. 276, 40847\u201340857 (2001).","journal-title":"J. Biol. Chem."},{"key":"537_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon, F., P\u00e9trilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237\u2013241 (2006).","journal-title":"Nature"},{"key":"537_CR32","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.4049\/jimmunol.1002720","volume":"186","author":"G Guarda","year":"2011","unstructured":"Guarda, G. et al. Differential expression of NLRP3 among hematopoietic cells. J. Immunol. 186, 2529\u20132534 (2011).","journal-title":"J. Immunol."},{"key":"537_CR33","doi-asserted-by":"crossref","unstructured":"Deora, V. et al. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia 68, 407\u2013421.","DOI":"10.1002\/glia.23728"},{"key":"537_CR34","doi-asserted-by":"crossref","unstructured":"Tzeng, T. C. et al. A fluorescent reporter mouse for inflammasome assembly demonstrates an important role for cell-bound and free ASC specks during in vivo infection. Cell Rep. 16, 571\u2013582 (2016).","DOI":"10.1016\/j.celrep.2016.06.011"},{"key":"537_CR35","first-page":"414","volume":"3","author":"A Gombault","year":"2012","unstructured":"Gombault, A., Baron, L. & Couillin, I. ATP release and purinergic signaling in NLRP3 inflammasome activation. Front. Immunol. 3, 414 (2012).","journal-title":"Front. Immunol."},{"key":"537_CR36","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","volume":"172","author":"J Mestas","year":"2004","unstructured":"Mestas, J. & Hughes, C. C. W. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172, 2731\u20132738 (2004).","journal-title":"J. Immunol."},{"key":"537_CR37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11302-016-9546-z","volume":"13","author":"MW Metzger","year":"2017","unstructured":"Metzger, M. W. et al. Genetically dissecting P2rx7 expression within the central nervous system using conditional humanized mice. Purinergic Signal. 13, 153\u2013170 (2017).","journal-title":"Purinergic Signal."},{"key":"537_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/iovs.61.10.4","volume":"61","author":"S Narendran","year":"2020","unstructured":"Narendran, S. et al. A clinical metabolite of azidothymidine inhibits experimental choroidal neovascularization and retinal pigmented epithelium degeneration. Invest. Ophthalmol. Vis. Sci. 61, 4 (2020).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"537_CR39","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0039-6257(03)00030-4","volume":"48","author":"J Ambati","year":"2003","unstructured":"Ambati, J., Ambati, B. K., Yoo, S. H., Ianchulev, S. & Adamis, A. P. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv. Ophthalmol. 48, 257\u2013293 (2003).","journal-title":"Surv. Ophthalmol."},{"key":"537_CR40","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou, Y. et al. Ageing as a risk factor for neurodegenerative disease. Nat. Rev. Neurol. 15, 565\u2013581 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"537_CR41","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/acel.12362","volume":"14","author":"SC Johnson","year":"2015","unstructured":"Johnson, S. C., Dong, X., Vijg, J. & Suh, Y. Genetic evidence for common pathways in human age-related diseases. Aging Cell 14, 809\u2013817 (2015).","journal-title":"Aging Cell"},{"key":"537_CR42","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/511405a","volume":"511","author":"L Fontana","year":"2014","unstructured":"Fontana, L., Kennedy, B. K. & Longo, V. D. Medical research: treat ageing. Nature 511, 405\u2013406 (2014).","journal-title":"Nature"},{"key":"537_CR43","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C L\u00f3pez-Ot\u00edn","year":"2013","unstructured":"L\u00f3pez-Ot\u00edn, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194 (2013).","journal-title":"Cell"},{"key":"537_CR44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.smim.2018.09.001","volume":"40","author":"E Latz","year":"2018","unstructured":"Latz, E. & Duewell, P. NLRP3 inflammasome activation in inflammaging. Semin. Immunol. 40, 61\u201373 (2018).","journal-title":"Semin. Immunol."},{"key":"537_CR45","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.cmet.2019.10.006","volume":"30","author":"CD Camell","year":"2019","unstructured":"Camell, C. D. et al. Aging induces an Nlrp3 inflammasome-dependent expansion of adipose B cells that impairs metabolic homeostasis. Cell Metab. 30, 1024\u20131039.e6 (2019).","journal-title":"Cell Metab."},{"key":"537_CR46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.molimm.2016.11.016","volume":"84","author":"MJ Geerlings","year":"2017","unstructured":"Geerlings, M. J., de Jong, E. K. & den Hollander, A. I. The complement system in age- related macular degeneration: a review of rare genetic variants and implications for personalized treatment. Mol. Immunol. 84, 65\u201376 (2017).","journal-title":"Mol. Immunol."},{"key":"537_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-1-4419-5635-4_2","volume":"703","author":"PF Zipfel","year":"2010","unstructured":"Zipfel, P. F., Lauer, N. & Skerka, C. The role of complement in AMD. Adv. Exp. Med. Biol. 703, 9\u201324 (2010).","journal-title":"Adv. Exp. Med. Biol."},{"key":"537_CR48","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/sj.eye.6702176","volume":"20","author":"S Sivaprasad","year":"2006","unstructured":"Sivaprasad, S. & Chong, N. V. The complement system and age-related macular degeneration. Eye 20, 867\u2013872 (2006).","journal-title":"Eye"},{"key":"537_CR49","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/bjophthalmol-2015-307213","volume":"100","author":"S Cao","year":"2016","unstructured":"Cao, S. et al. CFH Y402H polymorphism and the complement activation product C5a: effects on NF-\u03baB activation and inflammasome gene regulation. Br. J. Ophthalmol. 100, 713\u2013718 (2016).","journal-title":"Br. J. Ophthalmol."},{"key":"537_CR50","doi-asserted-by":"crossref","unstructured":"Klein, R. J. et al. Complement factor H polymorphism in age-related macular degeneration. Science 308, 385\u2013389 (2005).","DOI":"10.1126\/science.1109557"},{"key":"537_CR51","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1126\/science.1110189","volume":"308","author":"AO Edwards","year":"2005","unstructured":"Edwards, A. O. et al. Complement factor H polymorphism and age-related macular degeneration. Science 308, 421\u2013424 (2005).","journal-title":"Science"},{"key":"537_CR52","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1167\/iovs.14-16089","volume":"56","author":"B Aredo","year":"2015","unstructured":"Aredo, B. et al. A chimeric Cfh transgene leads to increased retinal oxidative stress, inflammation, and accumulation of activated subretinal microglia in mice. Invest. Ophthalmol. Vis. Sci. 56, 3427\u20133440 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"537_CR53","doi-asserted-by":"publisher","first-page":"31189","DOI":"10.1074\/jbc.M115.671180","volume":"290","author":"C Brandstetter","year":"2015","unstructured":"Brandstetter, C., Holz, F. G. & Krohne, T. U. Complement component C5a primes retinal pigment epithelial cells for inflammasome activation by lipofuscin-mediated photooxidative damage. J. Biol. Chem. 290, 31189\u201331198 (2015).","journal-title":"J. Biol. Chem."},{"key":"537_CR54","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1073\/pnas.0408835103","volume":"103","author":"M Nozaki","year":"2006","unstructured":"Nozaki, M. et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc. Natl Acad. Sci. USA 103, 2328\u20132333 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"537_CR55","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nri3459","volume":"13","author":"J Ambati","year":"2013","unstructured":"Ambati, J., Atkinson, J. P. & Gelfand, B. D. Immunology of age-related macular degeneration. Nat. Rev. Immunol. 13, 438\u2013451 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"537_CR56","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1182\/blood-2013-05-502229","volume":"122","author":"E Asgari","year":"2013","unstructured":"Asgari, E. et al. C3a modulates IL-1\u03b2 secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. Blood 122, 3473\u20133481 (2013).","journal-title":"Blood"},{"key":"537_CR57","doi-asserted-by":"publisher","first-page":"7122","DOI":"10.1167\/iovs.15-17440","volume":"56","author":"T Mizutani","year":"2015","unstructured":"Mizutani, T. et al. Nucleoside reverse transcriptase inhibitors suppress laser-induced choroidal neovascularization in mice. Invest. Ophthalmol. Vis. Sci. 56, 7122\u20137129 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"537_CR58","doi-asserted-by":"crossref","unstructured":"Ambati J. et al. Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development. Nat. Commun. 11, 1\u201312 (2020).","DOI":"10.1038\/s41467-020-18528-z"},{"key":"537_CR59","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/j.1471-4159.2005.03407.x","volume":"95","author":"S Barghorn","year":"2005","unstructured":"Barghorn, S. et al. Globular amyloid \u03b2-peptide1-42 oligomer-A homogenous and stable neuropathological protein in Alzheimer\u2019s disease. J. Neurochem. 95, 834\u2013847 (2005).","journal-title":"J. Neurochem."},{"key":"537_CR60","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1046\/j.1471-4159.2001.00592.x","volume":"79","author":"MP Lambert","year":"2001","unstructured":"Lambert, M. P. et al. Vaccination with soluble A\u03b2 oligomers generates toxicity-neutralizing antibodies. J. Neurochem. 79, 595\u2013605 (2001).","journal-title":"J. Neurochem."},{"key":"537_CR61","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nature02664","volume":"430","author":"S Mariathasan","year":"2004","unstructured":"Mariathasan, S. et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213\u2013218 (2004).","journal-title":"Nature"},{"key":"537_CR62","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki, N. et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526, 666\u2013671 (2015).","journal-title":"Nature"},{"key":"537_CR63","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nature04517","volume":"440","author":"TD Kanneganti","year":"2006","unstructured":"Kanneganti, T. D. et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin\/Nalp3. Nature 440, 233\u2013236 (2006).","journal-title":"Nature"},{"key":"537_CR64","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nature09830","volume":"471","author":"H Kaneko","year":"2011","unstructured":"Kaneko, H. et al. DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature 471, 325\u2013330 (2011).","journal-title":"Nature"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-021-00537-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-021-00537-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-021-00537-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T14:16:55Z","timestamp":1669817815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-021-00537-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,14]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["537"],"URL":"https:\/\/doi.org\/10.1038\/s41392-021-00537-z","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,14]]},"assertion":[{"value":"18 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.A. is a co-founder of iVeena Holdings, iVeena Delivery Systems, and Inflammasome Therapeutics, and has been a consultant for Allergan, Biogen, Boehringer-Ingelheim, Immunovant, Janssen, Olix Pharmaceuticals, Retinal Solutions, and Saksin LifeSciences unrelated to this work. J.A. and B.D.G. are co-founders of DiceRx. J.A., B.D.G., S.N., K.A., S.W., I.A., M.A., and F.P. are named as inventors on patent applications filed by the University of Virginia or the University of Kentucky. S.R.S. has been a consultant for 4DMT, Allergan, Amgen, Centervue, Heidelberg, Roche\/Genentech, Novartis, Optos, Regeneron, and Thrombogenics and has received research funding from Carl Zeiss Meditec, all unrelated to this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}